A systematic review of patient-reported and economic outcomes: Value to stakeholders in the decision-making process in patients with type 2 diabetes mellitus

Clinical Therapeutics

Volumn 33, Issue 9, 2011, Pages 1225-1245

  Vieta, Ana ^a   Badia, Xavier ^a   Sacristán, José A ^b  

^a IQVIA   (United States)

^b DCRandT   (Spain)

Author keywords

Economic outcomes; Health decision making; Patient reported outcomes; Type 2 diabetes mellitus

Indexed keywords

ABSENTEEISM; CLASSIFICATION; CLINICAL TRIAL (TOPIC); DISABILITY; ECONOMIC EVALUATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDITY; WORK CAPACITY;

COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; HUMANS; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION;

EID: 80053005298     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.07.013     Document Type: Review

References (222)

1. Gulliford M., Naithani S., Morgan M. What is 'continuity of care'?. J Health Serv Res Policy 2006, 11:248-250.
2. Okma K.G. European Health Care Reform: analysis of current strategies. J Health Polit Pol Law 1999, 24:835-840.
3. Thomson C.R., Berwick D.M. What can the UK learn from the USA about improving the quality and safety of healthcare?. Clin Med 2006, 6:551-558.
4. Crawford M.J., Rutter D., Manley C., et al. Systematic review of involving patients in the planning and development of health care. BMJ 2002, 325:1263.
5. The public health guidance development process: an overview for stakeholders including public health practitioners, policy makers and the public March 2006, National Institute for Clinical Excellence, National Institute for Clinical Excellence, London, England, Accessed February 1, 2008. http://www.nice.org.uk.
6. Badía X., del Llano J. Health Outcomes Research [in Spanish]. Med Clin (Barc) 2000, 114(Suppl 3):1-7.
7. Crawford B.L., Taylor L.S., Seipert B.S., Lush M. The imperative of outcomes analysis: an integration of traditional and nontraditional outcomes measures. J Nurs Care Qual 1996, 10:33-40.
8. Lipscomb J., Gotay C.C., Snyder C. Outcomes Assessment in Cancer: Measures, Methods, and Applications 2005, Cambridge University Press Inc, New York, NY.
9. Kozma C.M., Reeder C.E., Schulz R.M. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993, 15:1121-1132.
10. Vázquez V.C., González V.C., Ruiz E.M., et al. Assessment of health outcomes in the type 2 diabetes process [in Spanish]. Aten Primaria 2011, 43:127-133.
11. Guide to the methods of technology appraisal NICE, Accessed July 22, 2010. http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf.
12. Speight J., Barendse S.M. FDA guidance on patient reported outcomes. BMJ 2010, 21:c2921.
13. Siegel J.N. Development of an FDA guidance document for clinical trials in SLE. Lupus 1999, 8:581-585.
14. Wilkin D., Hallam L., Doggett M. Measures of Need and Outcome for Primary Health Care 1994, Oxford University Press Inc, New York, NY.
15. Health Outcomes Core Library Recommendations. The National Information Center on Health Services Research and Health Care Technology, National Library of Medicine. Academy Health, Washington, DC - July 14, 2004 Accessed November 1, 2010. http://www.nlm.nih.gov/nichsr/corelib/houtcomes.html.
16. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
17. Kessler R.C., Barber C., Beck A., et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med 2003, 45:156-174.
18. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med 2009, 6:e1000100. Accessed July 25, 2010. 10.1371/journal.pmed.1000100.
19. A guideline developers' handbook (Publication no. 50) [monographic publication in the Internet] 2001, Scottish Intercollegiate Guidelines Network, SIGN, Edinburgh, [Updated may 2004], Accessed February 1, 2008. http://www.sign.ac.uk/guidelines/fulltext/50/index.html.
20. Clarke M, Oxman AD, eds. Cochrane Reviewer manual 4.1.6 [Update January 2003; Spanish version] [cited on Nov, 12 2007]. Accessed April 1, 2008. http://www.cochrane.es/?q=es/handbook.
21. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006, 11:79. US Dept of Health and Human Services, FDA Center for Drug Evaluation and Research; US Dept of Health and Human Services FDA Center for Biologics Evaluation and Research; US Dept of Health and Human Services FDA Center for Devices and Radiological Health.
22. Outcome measurement in VHA mental health services-systematic review. Technology Assessment Unit, Office of Patient Care Services, US Dept of Veterans Affairs (VATAP), 2002 US Dept of Veterans Affairs, Accessed July 7, 2009. http://www.va.gov/vatap/.
23. Sansoni J., Marosszeky N., Fleming G., Sansoni E. Selecting Tools for ACAT Assessment: A Report for the Aged Care Assessment Program (ACAP) Expert Clinical Reference Group. Centre for Health Service Development, University of Wollongong. Report for the Aged Care Assessment Program, Australian Government Dept of Health and Ageing, Canberra 2010 Accessed October 3, 2010. http://immunise.health.gov.au/internet/main/publishing.nsf/Content/B806570749DC1C79CA2572FB001D6366/$File/ECRG%20Final%20Report.pdf.
24. Adriaanse M.C., Dekker J.M., Spijkerman A.M., et al. Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabet Med 2004, 21:1075-1081.
25. Hill-Briggs F., Gary T.L., Bone L.R., et al. Medication adherence and diabetes control in urban African Americans with type 2 diabetes. Health Psychol 2005, 24:349-357.
26. Hervás A., Zabaleta A., De Miguel G., et al. Health Related Quality of life in patients with diabetes mellitus type 2 [in Spanish]. An Sist Sanit Navar 2007, 30:45-52.
27. Valensi P., Girod I., Baron F., et al. Quality of life and clinical correlates in patients with diabetic foot ulcers. Diabetes Metab 2005, 31(3 Pt 1):263-271.
28. Rejeski W.J., Lang W., Neiberg R.H., et al. Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. Obesity (Silver Spring) 2006, 14:870-883. Look AHEAD Research Group.
29. Clouet F., Excler-Cavailher G., Christophe B., et al. Type 2 diabetes and short form 36-items health survey [in French]. Diabetes Metab 2001, 27:711-717.
30. Ribu L., Hanestad B.R., Moum T., et al. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res 2007, 16:179-189.
31. Hill-Briggs F., Gary T.L., Hill M.N., et al. Health-related quality of life in urban African American with type 2 diabetes. J Gen Intern Med 2002, 17:412-419.
32. Lloyd A., Sawyer W., Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 2001, 4:392-400.
33. Camacho F., Anderson R.T., Bell R.A., et al. Investigating correlates of health related quality of life in a low-income sample of patients with diabetes. Qual Life Res 2002, 11:783-796.
34. Mena Martín F.J., Martín Escudero J.C., Simal Blanco F., et al. Type 2 diabetes mellitus and health-related quality of life: results from the Hortega Study [in Spanish]. An Med Interna 2006, 23:357-360.
35. Papadopoulus A.A., Kontodimopoulus N., Frydas A., et al. Predictors of health-related quality of life in type II diabetic patients in Greece. BCM Public Health 2007, 7:186.
36. Alonso J., Prieto L., Antó J.M. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results [in Spanish]. Med Clin (Barc) 1995, 104:771-776.
37. Thommasen H.V., Berkowitz J., Thommasen A.T., Michalos A.C. Understanding relationships between diabetes mellitus and health-related quality of life in a rural community. Rural Remote Health 2005, 5:441.
38. Woodcock A.J., Julious S.A., Kinmonth A.L., Campbell M.J. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res 2001, 10:661-670. Diabetes Care From Diagnosis Group.
39. Ohsawa I., Ishida T., Oshida Y., et al. Subjective health values of individuals with diabetes in Japan: comparison of utility values with the SF-36 scores. Diabetes Res Clin Pract 2003, 62:9-16.
40. Kamarul Imran M., Ismail A.A., Naing L., Wan Mohamad W.B. Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36. Singapore Med J 2010, 51:157-162.
41. Lee H.J., Chapa D., Kao C.W., et al. Depression, quality of life, and glycemic control in individuals with type 2 diabetes. J Am Acad Nurse Pract 2009, 21:214-224.
42. Miksch A., Hermann K., Rölz A., et al. Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany-a cross-sectional survey. Health Qual Life Outcomes 2009, 7:19.
43. Mier N., Bocanegra-Alonso A., Zhan D., et al. Health-related quality of life in a binational population with diabetes at the Texas-Mexico border. Rev Panam Salud Publica 2008, 23:154-163.
44. Collins M.M., O'Sullivan T., Harkins V., Perry I.J. Quality of life and quality of care in patients with diabetes experiencing different models of care. Diabetes Care 2009, 32:603-605.
45. Gallegos-Carrillo K., García-Peña C., Durán-Muñoz C.A., et al. Relationship between social support and the physical and mental wellbeing of older Mexican adults with diabetes. Rev Invest Clin 2009, 61:383-391.
46. Balukonis J., Melkus G.D., Chyun D. Grandparenthood status and health outcomes in midlife African American women with type 2 diabetes. Ethn Dis 2008, 18:141-146.
47. Arroyo J., Badía X., de la Calle H., et al. Management of type 2 diabetic patients in primary care in Spain [in Spanish]. Med Clin (Barc) 2005, 125:166-172. Grupo pro-Star.
48. Davis R.E., Morrissey M., Peters J.R., et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005, 21:1477-1483.
49. Lundkvist J., Berne C., Bolinder B., Jönsson L. The economic and quality of life impact of hypoglycaemia. Eur J Health Econ 2005, 6:197-202.
50. Holmes J., McGill S., Kind P., et al. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health 2000, 3(Suppl 1):47-51.
51. Ragnarson Tennvall G., Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000, 14:235-241.
52. Clarke P., Gray A., Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002, 22:340-349.
53. Redekop W.K., Koopmanschap M.A., Stolk R.P., et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002, 25:458-463.
54. Koopmanschap M. Coping with type II diabetes: the patient's perspective. Diabetologia 2002, 45:S18-S22. CODE-2 Advisory Board.
55. Mata Cases M., Roset Gamisans M., Badia Llach X., et al. Effect of type-2 diabetes mellitus on the quality of life of patients treated at primary care consultations in Spain [in Spanish]. Aten Primaria 2003, 31:493-499.
56. Bagust A., Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005, 14:217-230.
57. Sakamaki H., Ikeda S., Ikegami N., et al. Measurements of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health 2006, 9:47-53.
58. Glasziou P., Alexander J., Beller E., Clarke P. Which health-related quality of life score?. A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes 2007, 5:21. ADVANCE Collaborative Group.
59. Matza L.S., Boye K.S., Yurgin N. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Health Qual Life Outcomes 2007, 31:5-47.
60. Matza L.S., Boye K.S., Yurgin N., et al. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007, 16:1251-1265.
61. Hill-Briggs F., Gary T.L., Baptiste-Roberts K., Brancati F.L. Thirty-six-item short-form outcomes following a randomized controlled trial in type 2 diabetes. Diabetes Care 2005, 28:443-444.
62. Solli O., Stavem K., Kristiansen I.S. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010, 8:18.
63. Gorter K.J., Wens J., Khunti K., et al. The European EUCCLID pilot study on care and complications in an unselected sample of people with type 2 diabetes in primary care. Prim Care Diabetes 2010, 4:17-23.
64. Chang K. Comorbidities, quality of life and patients' willingness to pay for a cure for type 2 diabetes in Taiwan. Public Health 2010, 124:284-294.
65. Maddigan S.L., Feeny D.H., Johnson J.A. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making 2003, 23:489-501. DOVE Investigators.
66. Maddigan S.L., Feeny D.H., Johnson J.A. Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Qual Life Res 2004, 13:435-448. DOVE Investigators.
67. Maddigan S.L., Feeny D.H., Majumdar S.R., et al. Understanding the determinants of health for people with type 2 diabetes. Am J Public Health 2006, 96:1649-1655.
68. Maddigan S.L., Feeny D.H., Majumdar S.R., et al. Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes. J Clin Epidemiol 2006, 59:472-477.
69. Wexler D.J., Grant R.W., Wittenberg E., et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006, 49:1489-1497.
70. Bowker S.L., Pohar S.L., Johnson J.A. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes 2006, 4:17.
71. Sundaram M., Kavookjian J., Hicks Patrick J., et al. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 2007, 16:165-177.
72. Johnson J.A., Maddigan S.L. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Qual Life Res 2004, 13:449-456.
73. Huang M.F., Courtney M., Edwards H., McDowell J. Factors that affect health outcomes in adults with type 2 diabetes: a cross-sectional study. Int J Nurs Stud 2010, 47:542-549.
74. Donatti C., Wild D., Horblyuk R., et al. Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS). Diabetes Res Clin Pract 2008, 80:108-113.
75. Lee Y.Y., Lin J.L. The effects of trust in physician on self-efficacy, adherence and diabetes outcomes. Soc Sci Med 2009, 68:1060-1068.
76. Al-Shehri A.H., Taha A.Z., Bahnassy A.A., Salah M. Health-related quality of life in type 2 diabetic patients. Ann Saudi Med 2008, 28:352-360.
77. Grandy S., Chapman R.H., Fox K.M. Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes (SHIELD). Int J Clin Pract 2008, 62:562-568. SHIELD Study Group.
78. Huang E.S., Brown S.E., Thakur N., et al. Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care 2009, 32:311-316.
79. Matza L., Yurgin N., Boye K.S., et al. Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change. Curr Med Res Opin 2007, 23:2051-2062.
80. Leonardson G.R., Daniels M.C., Ness F.K., et al. Validity and reliability of the general well-being schedule with northern plains American Indians diagnosed with type 2 diabetes mellitus. Psychol Rep 2003, 93:49-58.
81. de Grauw W.J., van de Lisdonk E.H., van Gerwen W.H., et al. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?. Br J Gen Pract 2001, 51:527-532.
82. de Grauw W.J., van de Lisdonk E.H., Behr R.R., et al. The impact of type 2 diabetes mellitus on daily functioning. Fam Pract 1999, 16:133-139.
83. Botija Yagüe M.P., Lizán Tudela L., Gosalbes Soler V., et al. How does intensive therapy of cardiovascular risk factors affect health-related quality of life in diabetic patients [in Spanish]. Aten Primaria 2007, 39:227-233.
84. Esteban y Peña M.M., Hernandez Barrera V., Fernández Cordero X., et al. Self-perception of health status, mental health and quality of life among adults with diabetes residing in a metropolitan area. Diabetes Metab 2010, 36:305-311.
85. Paschalides C., Wearden A.J., Dunkerley R., et al. The associations of anxiety, depression and personal illness representations with glycaemic control and health-related quality of life in patients with type 2 diabetes mellitus. J Psychosom Res 2004, 57:557-564.
86. Hirsch A., Bartholomae C., Volmer T. Dimensions of quality of life in people with non-insulin dependent diabetes. Qual Life Res 2000, 9:207-218.
87. Wilson M., Moore M.P., Lunt H. Treatment satisfaction after commencement of insulin in type 2 diabetes. Diabetes Res Clin Pract 2004, 66:263-267.
88. Kolawole B.A., Mosaku S.K., Ikem R.T. A comparison of two measures of quality of life of Nigerian clinic patients with type 2 diabetes mellitus. Afr Health Sci 2009, 9:161-166.
89. Hänninen J., Takala J., Keinänen-Kiukaanniemi S. Good continuity of care may improve quality of life in type 2 diabetes. Diabetes Res Clin Pract 2001, 51:21-27.
90. Hänninen J., Takala J., Keinänen-Kiukaanniemi S. Quality of life in NIDDM patients assessed with the SF-20 questionnaire. Diabetes Res Clin Pract 1998, 42:17-27.
91. Pitale S., Kernan-Schroeder D., Emanuele N., et al. Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus. J Diabetes Complications 2005, 19:207-211. VACSDM Study Group.
92. Eljedi A., Mikolajczyk R., Kraemer A., Laaser U. Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study. BMC Public Health 2006, 6:268.
93. Rose M., Fliege H., Hildebrandt M., et al. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care 2002, 25:35-42.
94. Huang M.C., Hung C.H. Quality of life and its predictors for middle-aged and elderly patients with type 2 diabetes mellitus. J Nurs Res 2007, 15:193-201.
95. Pibernik-Okanoviœ M. Psychometric properties of the World Health Organisation quality of life questionnaire (WHOQOL-100) in diabetic patients in Croatia. Diabetes Res Clin Pract 2001, 51:133-143.
96. Chaveepojnkamjorn W., Pichainarong N., Schelp F.P., Mahaweerawat U. Quality of life and compliance among type 2 diabetic patients. Southeast Asian J Trop Med Public Health 2008, 39:328-334.
97. de Visser C.L., Bilo H.J., Groenier K.H., et al. The influence of cardiovascular disease on quality of life in type 2 diabetes. Qual Life Res 2002, 11:249-261.
98. Kleefstra N., Ubink-Veltmaat L.J., Houweling S.T., et al. Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med 2005, 63:215-221.
99. Goddijn P.P., Bilo H.J., Feskens E.J., et al. Longitudinal study on glycaemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified patients. Diabet Med 1999, 16:23-30.
100. Mateo J.F., Gil-Guillén V.F., Mateo E., et al. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int J Clin Pract 2006, 60:422-428.
101. Bezie Y., Molina M., Hernandez N., et al. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab 2006, 32:611-616.
102. Guillausseau P.J. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab 2003, 29:79-81.
103. Krapek K., King K., Warren S.S., et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004, 38:1357-1362.
104. Villarreal-Ríos E., Salinas-Martínez A.M., Medina-Jáuregui A., et al. The cost of diabetes mellitus and its impact on health spending in Mexico. Arch Med Res 2000, 31:511-514.
105. Odegard P.S., Gray S.L. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008, 34:692-697.
106. Kuo Y.F., Raji M.A., Markides K.S., et al. Inconsistent use of diabetes medications, diabetes complications and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care 2003, 26:3054-3060.
107. Lamarca R., Alonso J., Santed R., Prieto L. Performance of a perceived health measure in different groups of the population: a comprehensive study in Spain. J Clin Epidemiol 2001, 54:127-135.
108. Coelho R., Amorim I., Prata J. Coping styles and quality of life in patients with non-insulin-dependent diabetes mellitus. Psychosomatics 2003, 44:312-318.
109. Kacerovsky-Bielesz G., Lienhardt S., Hagenhofer M., et al. Sex-related psychological effects on metabolic control in type 2 diabetes mellitus. Diabetologia 2009, 52:781-788.
110. Adriaanse M.C., Dekker J.M., Spijkerman A.M., et al. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: the Hoorn Screening Study. Qual Life Res 2005, 14:1501-1509.
111. Trovato G.M., Catalano D., Martines G.F., et al. Psychological stress measure in type 2 diabetes. Eur Rev Med Pharmacol Sci 2006, 10:69-74.
112. Weinman J., Petrie K.J., Moss-Morris R., Horne R. The illness perception questionnaire: a new method for assessing cognitive representation of illness. Psychol Health 1996, 11:431-445.
113. Broadbent E., Petrie K.J., Main J., Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006, 60:631-637.
114. Coffey J.T., Brandle M., Zhou H., et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002, 25:2238-2243.
115. Griffiths R., Jayasuriya R., Maitland H. Development of a client-generated health outcome measure for community nursing. Aust N Z J Public Health 2000, 24:529-535.
116. Grant R.W., Devita N.G., Singer D.E., Meigs J.B. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003, 26:1408-1412.
117. Farmer A., Kinmonth A.L., Sutton S. Measuring beliefs about taking hypoglycaemic medication among people with type 2 diabetes. Diabet Med 2006, 23:265-270.
118. Guck T.P., Banfield M.A., Tran S.M., et al. A psychosocial taxonomy of patients with diabetes: validation in a primary care setting. Diabet Med 2008, 25:716-721.
119. Andrade F.C. Measuring the impact of diabetes on life expectancy and disability-free life expectancy among older adults in Mexico. J Gerontol B Psychol Sci Soc Sci 2010, 65B:381-389.
120. García A.A. Clinical and life quality differences between Mexican American diabetic patients at a free clinic and a hospital-affiliated clinic in Texas. Public Health Nurs 2008, 25:149-158.
121. Misra R., Lager J. Predictors of quality of life among adults with type 2 diabetes mellitus. J Diabetes Complications 2008, 22:217-223.
122. Misra R., Lager J. Ethnic and gender differences in psychosocial factors, glycemic control, and quality of life among adult type 2 diabetic patients. J Diabetes Complications 2009, 23:54-64.
123. Kannan H., Thompson S., Bolge S.C. Economic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertension among individuals who are overweight or obese. J Occup Environ Med 2008, 50:542-549.
124. Charpentier G., Fleury F., Dubroca I., et al. Electronic pill-boxes in the evaluation of oral hypoglicemic agent compliance. Diabetes Metab 2005, 31:189-195.
125. Bradley C., Todd C., Gorton T., et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8:79-91.
126. Cavanaugh K., Wallston K.A., Gebretsadik T., et al. Addressing literacy and numeracy to improve diabetes care: two randomized controlled trials. Diabetes Care 2009, 32:2149-2155.
127. Vandekerckhove M., Vermeire E., Weeren A., Van Royen P. Validation of the Diabetes Obstacles Questionnaire (DOQ) to assess obstacles in living with type 2 diabetes in a Belgian population. Prim Care Diabetes 2009, 3:43-47.
128. Boyer J.G., Earp J.A. The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Med Care 1997, 35:440-453.
129. Khader Y.S., Bataineh S., Batayha W. The Arabic version of Diabetes-39: psychometric properties and validation. Chronic Illn 2008, 4:257-263.
130. Goddijn P., Bilo H., Meadows K., et al. Validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapy. Qual Life Res 1996, 5:433-442.
131. Davis T.M., Clifford R.M., Davis W.A. Effect of insulin therapy on quality of life in type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2001, 52:63-71. Fremantle Diabetes Study.
132. Reliability and validity of a diabetes quality of life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 1988, 11:725-732.
133. Reviriego J., Millan M.D., Millan M. Evaluation of the diabetes quality-of-life in a Spanish population. An experience of translation and reliability. Pharmacoeconomics 1996, 10:614-622.
134. Delahanty L.M., Grant R.W., Wittenberg E., et al. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with type 2 diabetes. Diabet Med 2007, 24:48-54.
135. Welch G.W., Jacobson A.M., Polonsky W.H. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diabetes Care 1997, 20:760-766.
136. Welch G., Schwartz C.E., Satiago-Kelly P., et al. Disease-related emotional distress of Hispanic and non-Hispanic type 2 diabetes patients. Ethn Dis 2007, 17:541-547.
137. Welch G., Weinger K., Anderson B., Polonsky W.H. Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabet Med 2003, 20:69-72.
138. Chawla A., Saha C., Marrero D.G. A novel application of the Problem Areas in Diabetes (PAID) instrument to improve glycemic control and patient satisfaction. Diabetes Educ 2010, 36:337-344.
139. Fitzgerald J.T., Davis W.K., Connell C.M., et al. Development and validation of the Diabetes Care Profile. Eval Health Prof 1996, 19:208-230.
140. Fitzgerald J.T., Anderson R.M., Gruppen L.D., et al. The reliability of the Diabetes Care Profile for African Americans. Eval Health Prof 1998, 21:52-65.
141. Cunningham V., Mohler M.J., Wendel C.S., et al. Reliability and validity of the DCP among hispanic veterans. Eval Health Prof 2005, 28:447-463.
142. Fitzgerald J.T., Gruppen L.D., Anderson R.M., et al. The influence of treatment modality and ethnicity on attitudes in type 2 diabetes. Diabetes Care 2000, 23:313-318.
143. Yanover T., Sacco W.P. Reliability of diabetes-specific social support scales. Psychol Health Med 2008, 13:627-631.
144. Khattab M., Khader Y.S., Al-Khawaldeh A., Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications 2010, 24:84-89.
145. Carey M.P., Jorgensen R.S., Weinstock R.S., et al. Reliability and validity of the Appraisal of Diabetes Scale. J Behav Med 1991, 14:43-51.
146. Cox D.J., Irvine A., Gonder-Frederick L., et al. Fear of hypoglycemia: quantification, validation and utilization. Diabetes Care 2000, 23:1199-1200.
147. Abetz L., Sutton M., Brady L., et al. The Diabetic Foot Ulcer Scale (DFS): a quality of life instrument for use in clinical trials. Pract Diab Int 2002, 19:167-175.
148. Snoek F.J., Mollema E.D., Heine R.J., et al. Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings. Diabet Med 1997, 14:871-876.
149. Mollema E.D., Snoek F.J., Pouwer F., et al. Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care 2000, 23:765-769.
150. Anderson R.M., Funnell M.M., Fitzgerald J.T., Marrero D.G. The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care 2000, 23:739-743.
151. Anderson R.M., Fitzgerald J.T., Gruppen L.D., et al. The Diabetes Empowerment Scale-Short Form (DES-SF). Diabetes Care 2003, 26:1641-1642.
152. Talbot F., Nouwen A., Gingras J., et al. The assessment of diabetes-related cognitive and social factors: the Multidimensional Diabetes Questionnaire. J Behav Med 1997, 20:291-312.
153. Hearnshaw H., Wright K., Dale J., et al. Development and validation of the Diabetes Obstacles Questionnaire (DOQ) to assess obstacles in living with type 2 diabetes. Diabet Med 2007, 24:878-882.
154. Tang T.S., Brown M.B., Funnell M.M., Anderson R.M. Social support, quality of life, and self-care behaviors amongAfrican Americans with type 2 diabetes. Diabetes Educ 2008, 34:266-276.
155. Tang Y.H., Pang S.M., Chan M.F., et al. Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitus. J Adv Nurs 2008, 62:74-83.
156. García A.A. Symptom prevalence and treatments among Mexican Americans with type 2 diabetes. Diabetes Educ 2005, 31:543-554.
157. Maddigan S.L., Majumdar S.R., Johnson J.A. Understanding the complex associations between patient-provider relationships, self-care behaviours, and health-related quality of life in type 2 diabetes: a structural equation modeling approach. Qual Life Res 2005, 14:1489-1500.
158. Wallston K.A., Rothman R.L., Cherrington A. Psychometric properties of the Perceived Diabetes Self-management Scale (PDSMS). J Behav Med 2007, 30:395-401.
159. Vileikyte L., Peyrot M., Bundy C., et al. The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 2003, 26:2549-2555.
160. Shen W., Kotsanos J.G., Huster W.J., et al. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 1999, 37(4 Suppl):AS45-AS66.
161. Sato E., Suzukamo Y., Miyashita M., Kazuma K. Development of a diabetes diet-related quality of life scale. Diabetes Care 2004, 27:1271-1275.
162. Joish V.N., Malone D.C., Wendel C., et al. Development and validation of a diabetes mellitus severity index: a risk-adjustment tool for predicting health care resource use and costs. Pharmacotherapy 2005, 25:676-684.
163. Gafarian C.T., Heiby E.M., Blair P., Singer F. The Diabetes Time Management Questionnaire. Diabetes Educ 1999, 25:585-592.
164. Peyrot M., Rubin R.R. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care 2005, 28:53-58.
165. Cappelleri J.C., Cefalu W.T., Rosenstock J., et al. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther 2002, 24:552-564.
166. Anderson R.M., Fitzgerald J.T., Funnell M.M., Gruppen L.D. The third version of the Diabetes Attitude Scale. Diabetes Care 1998, 21:1403-1407.
167. Brod M., Skovlund S.E., Wittrup-Jensen K.U. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006, 15:481-491.
168. Fitzgerald J.T., Funnell M.M., Hess G.E., et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care 1998, 21:706-710.
169. Harris M.A., Wysocki T., Sadler M., et al. Validation of a structured interview for the assessment of diabetes self-management. Diabetes Care 2000, 23:1301-1304.
170. Egede L.E., Ellis C. Development and psychometric properties of the 12-item diabetes fatalism scale. J Gen Intern Med 2010, 25:61-66.
171. Klis S., Vingerhoets A.J., de Wit M., et al. Pictorial Representation of Illness and Self Measure Revised II (PRISM-RII): a novel method to assess perceived burden of illness in diabetes patients. Health Qual Life Outcomes 2008, 6:104.
172. Redekop W.K., Koopmanschap M.A., Rutten G.E., et al. Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices. Diabet Med 2002, 19:246-253.
173. Schmitt-Koopmann I., Schwenkglenks M., Spinas G.A., Szucs T.D. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health 2004, 14:3-9.
174. Mata M., Antoñanzas F., Tafalla M., Sanz P. The cost of type 2 diabetes in Spain: the CODE-2 study [in Spanish]. Gac Sanit 2002, 16:511-520.
175. Garattini L., Tediosi F., Chiaffarino F., et al. The outpatient cost of diabetes care in Italian diabetes centers. Value Health 2001, 4:251-257. Gruppo di Studio Rilevazione Economica dei Costi e Risorse nel Diabete.
176. Wang W., Fu C., Zhuo H., et al. Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China. BMC Health Serv Res 2010, 10:244.
177. Oster R.T., Virani S., Strong D., et al. Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta. Can Fam Physician 2009, 55:386-893.
178. Liebl A., Breitscheidel L., Nicolay C., Happich M. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study. Curr Med Res Opin 2008, 24:2349-2358.
179. Pelletier E.M., Shim B., Ben-Joseph R., Caro J.J. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. Pharmacoeconomics 2009, 27:479-490.
180. Durden E.D., Alemayehu B., Bouchard J.R., et al. Direct health care costs of patients with type 2 diabetes within a privately insured employed population, 2000 and 2005. J Occup Environ Med 2009, 51:1460-1465.
181. Wang W., McGreevey W.P., Fu C., et al. Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care 2009, 15:593-601.
182. Dall T.M., Mann S.E., Zhang Y., et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag 2009, 12:103-110.
183. Henriksson F., Agardh C.D., Berne C., et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2001, 249:391-393.
184. Wallemacq C., van Gaal L.F., Scheen A.J. The cost of type 2 diabetes: Summary of the Cost of Diabetes in Europe-Type II study (CODE-2) and analysis of the situation in Belgium. [in French]. Rev Med Liege 2005, 60:278-284.
185. Garattini L., Chiaffarino F., Cornago D., et al. Direct medical costs unequivocally related to diabetes in Italian specialized centres. Eur J Health Econ 2004, 5:15-21. Study Group RECORD Rilevazione Economica del Costi e Risorse nel Diabete.
186. Olveira-Fuster G., Olvera-Márquez P., Carral-Sanlaureano F., et al. Excess hospitalizations, hospital days, and inpatient costs among people with diabetes in Andalusia, Spain. Diabetes Care 2004, 27:1904-1909.
187. McEwan P., Peters J.R., Bergenheim K., Currie C.J. Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster). Curr Med Res Opin 2006, 22:121-129.
188. Williams R., Van Gaal L., Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002, 45:S13-S17. CODE-2 Advisory Board.
189. Jönsson L., Bolinder B., Lundkvist J. Cost of hypoglycemia in patients with type 2 diabetes in Sweden. Value Health 2006, 9:193-198.
190. Clarke P., Gray A., Legood R., et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No 65). Diabet Med 2003, 20:442-450.
191. O'Brien J., Patrick A., Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003, 25:1017-1038.
192. Reunanen A., Kangas T., Martikainen J., Klaukka T. Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care 2000, 23:1265-1271.
193. Brown J.B., Nichols G.A., Glauber H.S., et al. Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus. Am J Health Syst Pharm 2001, 58:151-157.
194. Wang W., Fu C.W., Pan C.Y., et al. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?. Value Health 2009, 12:923-929.
195. Kumar A., Nagpal J., Bhartia A. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey. J Assoc Physicians India 2008, 56:667-674.
196. Testa M.A., Simonson D.C. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998, 280:1490-1496.
197. Egede L.E. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 2004, 27:1751-1753.
198. Licciardone J.C., Kotsanos J.G., Brinkman-Kaplan V., et al. Resource utilization and work or school loss reported by patients with diabetes: experience in diabetes training programs. Am J Manag Care 1997, 3:777-782.
199. Ramsey S., Summers K.H., Leong S.A., et al. Productivity and medical costs of diabetes in a large employer population. Diabetes Care 2002, 25:23-29.
200. Mayfield J.A., Deb P., Whitecotton L. Work disability and diabetes. Diabetes Care 1999, 22:1105-1109.
201. Skerjanc A. Sickness absence in diabetic employees. Occup Environ Med 2001, 58:432-436.
202. Davis W.A., Knuiman M.W., Hendrie D., Davis T.M. Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle diabetes study. Diabetes Care 2005, 28:329-336.
203. González P., Faure E., Del Castillo A. Cost of diabetes mellitus in Spain [in Spanish]. Med Clin (Barc) 2006, 127:776-784. Grupo de Trabajo para el Estudio del Coste de la Diabetes.
204. Holmes J., Gear E., Bottomley J., et al. Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4). Health Policy 2003, 64:291-296.
205. van Roijen L., Essink-Bot M.L., Koopmanschap M.A., et al. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996, 12:405-415.
206. Plaveev O., Dimitrova Z., Petkova V., et al. Assessment of the decreased productivity of patients with diabetes type 2 in the Clinical Endocrynological Center Sofia, Bulgaria. Pharm Pract 2006, 4:204-207.
207. Lavigne J.E., Phelps C.E., Mushlin A., Lednar W.M. Reductions in individual work productivity associated with type 2 diabetes mellitus. Pharmacoeconomics 2003, 21:1123-1134.
208. Valdmanis V., Smith D.W., Page M.R. Productivity and economic burden associated with diabetes. Am J Public Health 2001, 91:129-130.
209. Dailey G., Kim M.S., Lian J.F. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitas. Clin Ther 2001, 23:1311-1320.
210. Bhattacharyya S.K., Else B.A. Medical costs of managed care in patients with type 2 diabetes mellitus. Clin Ther 1999, 21:2131-2142.
211. Palmer A.J., Roze S., Valentine W.J., et al. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004, 20(Suppl 1):S5-S26.
212. Delahanty L.M., Grant R.W., Wittenberg E., et al. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with type 2 diabetes. Diabet Med 2007, 24:48-54.
213. Grootenhuis P.A., Snoek F.J., Heine R.J., Bouter L.M. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med 1994, 11:253-261.
214. Bradley C., Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002, 18(Suppl 3):S64-S69.
215. Hirsch A., Bartholomae C., Volmer T. Dimensions of quality of life in people with non-insulin dependent diabetes. Qual Life Res 2000, 9:207-218.
216. Garrat A.M., Schmidt L., Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med 2002, 19:1-11.
217. el Achhab Y., Nejjari C., Chikri M., Lyoussi B. Disease-specific health-related quality of life instruments among adults diabetic: a systematic review. Diabetes Res Clin Pract 2008, 80:171-184.
218. Speight J., Reaney M.D., Barnard K.D. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med 2009, 26:315-327.
219. Gandhi G.Y., Murad M.H., Fyjiyoshi A., et al. Patient-important outcomes in registered diabetes trials. JAMA 2008, 299:2543-2549.
220. Groene O. Implementing health promotion in hospitals: manual and self-assessment forms. WHO Regional Office for Europe, Copenhagen, 2006 (WHOLIS e88584) Accessed March 12, 2009. http://www.ukaf.org.uk/HPHImplementationManual.pdf.
221. Are we choosing health?. The impact of policy on the delivery of health improvement programmes and services. The Audit Commission for local authorities and the National Health Service in England: July 2008 Accessed March 12, 2009. http://www.audit-commission.gov.uk/SiteCollectionDocuments/AuditCommissionReports/NationalStudies/AreWeChoosingHealth_tagged16Jul08REP.pdf.
222. Bren L. The importance of patient-reported outcomes ...it's all about the patients. FDA Consum 2006, 40:26-32.